PARATHYROID HYPERPLASIA

This adverse event was reported 56 times

PARATHYROID HYPERPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FORMALDEHYDE SOLUTION 1 0.2000
1 FORMALDEHYDE 7 0.1148
2 ETELCALCETIDE 7 0.0024
3 SEVELAMER HYDROCHLORIDE 1 0.0017
4 CHLORHEXIDINE GLUCONATE 7 0.0007
5 INSULIN DEGLUDEC AND LIRAGLUTIDE 1 0.0006
6 CLORAZEPATE DIPOTASSIUM 1 0.0005
7 CINACALCET HYDROCHLORIDE 17 0.0004
8 CALCITRIOL CAPSULES 0.25 MCG 7 0.0003
9 ELBASVIR AND GRAZOPREVIR 1 0.0002
See all drugs enriched for association with PARATHYROID HYPERPLASIA